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Abstract 
A UV spectrophotometric method was developed for the estimation of Telmisartan & 
Hydrochlorothiazide in Combined Tablet Dosage Form Using Simultaneous Equation Method. The drug 
obeyed the Beer’s law & shows good correlation near to r2 = 0.999 for Telmisartan & for Hydrochlorothiazide 
r
2
=0.999.Absorption maxima of Telmisartan 296.8 nm and Hydrochlorothiazide 271.2 nm. Beer’s law was 
obeyed in concentration rang of 5-30 µg/ml for Telmisartan & 2-12 µg/ml for Hydrochlorothiazide. The 
method has been validated for linearity, accuracy & precision. The recovery was 99.28 % for Telmisartan & 
99.26% for Hydrochlorothiazide. The developed method was found to be accurate, simple, precise, 
economical, and selective for simultaneous estimation of Telmisartan & Hydrochlorothiazide in tablet 
formulations. 
Keywords: Telmisartan, Hydrochlorothiazide, UV-Spectrophotometer simultaneous determination, , 
development and validation. 
 
1. Introduction 
It is antihypertensive drug it selectively 
blocks AT1 receptors and prevents stimulation of their 
receptors by angiotensin it produces vasodilatation 
and reduces peripheral resistance and blood pressure. 
Inhibition of central sympathetic tone, Blocks release 
of adrenaline, Inhibits Na and water retention in 
kidney and reduces fluid overload and preload. It is 
mainly used in hypertension. It is used for treating 
high blood pressure & accumulation of fluid. Works 
by blocking solute & fluid reabsorption in the 
kidneys, causing increase urine output. Also used to 
treat fluid accumulation and swelling (edema) of body 
caused by heart failure, cirrhosis, chronic kidney 
failure, corticosteroid medication and nephritic 
syndrome. TELM is chemically 4’-[(1,4’-Dimethyl-
2’-propyl-[2,6’-bi-1H-benzimidazol]-1’-yl)methyl]-
1,1’-biphenyl]-2-carboxylic acid. Hydrochlorothiazide 
(HCT) is one of the widely used thiazide diuretic 
which reduces reabsorption of electrolytes from the 
renal tubules and chemically 6-Chloro-3, 4-dihydro-
2H-1, 2, 4-benzothiazidine-7- sulfonamide-1,1-
dioxide. 
 
2. Experimental 
2.1 Selection of Solvents 
On the basis of solubility study methanol was selected 
as the solvent for dissolving TLM and HCTZ.  
2.2 Preparation of Standard Stock Solutions of 
TLM and HCTZ 
A) Telmisartan Standard Stock Solution [T]: An 
accurately weighed quantity of TLM (25 mg) was 
taken in 25 mL volumetric flask and dissolved in 
methanol (20 mL) with the help of ultrasonication for 
about 10 min. Then the volume was made up to the 
mark using methanol to get Telmisartan standard 
stock solution (1 mg / mL).   
B) Telmisartan Working Standard Solution [T1]: 
Telmisartan standard stock solution [T] (5 mL) was 
diluted to 50 mL using 50% v/v methanol to get 
working standard solution (100 µg / mL)   
C) Hydrochlorothiazide Standard Stock Solution [H]: 
An accurately weighed quantity of HCTZ (25 mg) 
was taken in 25 mL volumetric flask and dissolved in 
methanol (20 mL) with manual shaking. Then the 
volume was made up to the mark using methanol to 
get Hydrochlorothiazide standard stock solution (1 
mg / mL). 
D) Hydrochlorothiazide Working Standard Solution 
[H1]: 
Hydrochlorothiazide standard stock solution [H] (5 
mL) was diluted to 50 mL using 50% v/v methanol to 
get Hydrochlorothiazide working standard solution of 
(100 µg / mL) 
2.3 Determination of λ Max of Individual 
Component 
 An appropriate aliquot portion of TLM (0.5 
mL) and HCTZ (0.5 mL) were transferred to two 
separate 10 mL volumetric flasks, the volume was 
made up to the mark using 50 %v/v methanol to 
obtain TLM (5 µg/mL) and HCTZ (5 µg/mL). Drug 
solutions were scanned separately between 200 nm to 
400 nm. 
2.4 Determination of Overlay Spectra and 
Isoabsorptive Point 
 The overlain spectrum of both drugs was 
recorded (Fig. 4) and two wavelengths 296.8 nm (λ 
max of TLM) and 271.2 nm (λ max of HCTZ) were 
selected for further study. 
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 Fig. 1: Overlay Spectra of TLM and HCTZ 
 
 
2.5 Study of Beer-Lambert’s Law [Linearity 
study]: 
A) Linearity Study for TLM: Accurately measured 
aliquot portions of working standard solution of 
TLM [T1] (0.5 mL to 3 mL) was transferred to 
seven separate 10 mL volumetric flasks. The 
volume was made up to the mark using 50% v/v 
methanol to obtain concentrations (5-30 µg/mL). 
Absorbance of these solutions was measured at 
296.8 nm, (Table2) Calibration curve was 
plotted, absorbance Vs concentration as shown in 
(Fig. 5). 
B) Linearity Study for HCTZ: Accurately measured 
aliquot portions of working standard solution of 
HCTZ [H1] (0.2 mL to 1.2 mL) were transferred 
to seven separate 10 mL volumetric flasks. The 
volume was made up to the mark using 50% v/v 
methanol to obtain concentrations (2 – 12 
µg/mL). Absorbance of these solutions was 
measured at 271.2 nm, (Table 3). Calibration 
curve was plotted, absorbance Vs concentration 
as shown in (Fig. 6). 
 
Table 2: Linearity Study of TLM at 296.8 nm 
Sr. 
No. 
Concentration of 
TLM in    
[µg/mL] 
Absorbance  
Mean ± S.D. [n = 5] 
% 
R.S.D. 
1 0 0 0 
2 5 0.252±0.0016 0.63 
3 10 0.497±0.0048 0.96 
4 15 0.748± 0.0060 0.80 
5 20 1.137±0.0047 0.41 
6 25 1.258±0.0094 0.74 
7 30 1.488±0.0034 0.22 
 
Fig. 2: Calibration Curve of Telmisartan at 296.8 nm 
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Table3: Linearity Study of HCTZ at 271.2 nm 
 
Sr. 
No. 
Concentration of 
HCTZ [µg/mL] 
Absorbance  
Mean ± S.D. [n = 5] 
% 
R.S.D. 
1 0 0 0 
2 2 0.144 ± 0.0025 1.736 
3 4 0.270 ± 0.0021 0.77 
4 6 0.401 ± 0.0017 0.42 
5 8 0.531 ± 0.0044 0.82 
6 10 0.664 ± 0.0024 0.36 
7 12 0.796 ± 0.0079 0.99 
 
Fig. 6: Calibration Curve of HCTZ at 271.2 nm 
Wavelength 
Y = 0.065x + 0.005; r
2 
= 0.999 
 
 
2.6 Determination of E (1%, 1cm) at Selected 
Wavelengths: Aliquot portion of TLM working 
standard solution [T1] (3.2 mL) was transferred to five 
different 10 mL volumetric flaks and volume was 
made up to the mark to obtain the concentration (32 
g / mL). Similarly, aliquot portion of HCTZ from 
working standard solution [H1] (1 mL) was 
transferred to five different 10mL volumetric flask 
and volume was made up to the mark to obtain 
concentration (10 g / mL). The absorbance of each 
solution was measured at 296.8 nm and 271.2 nm. 
E (1%, 1cm) values of drugs were calculated using 
following formula; 
                                            Absorbance 
         E (1%, 1cm) = 
                                  Cocentration (g/100mL) 
 
Results of E (1%, 1cm) are shown in (Table 4) 
 
Table4: E (1%, 1cm) Values of TLM and HCTZ at 
296.8 nm and 271.2 nm 
 
  Sr. No. at 296.8 nm at 271.2 nm 
TLM HCTZ TLM HCTZ 
1  497.8 79 356.5 664 
2 498.7 79 356.8 664 
3 498.1 78 356.8 663 
4 498.75 79 357.1 665 
5 499.3 78 355.9 663 
6 498.75 80 355.9 666 
Mean ax1 = 
498.51 
ay1= 
78.8 
ax2 = 
356.5 
Ay2= 
664.1 
S.D 0.52 0.752 0.501 1.169 
% RSD 0.1043 0.9543 0.140 0.176 
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2.7 Estimation of Laboratory Mixture by Proposed 
Method 
In order to see the feasibility of proposed 
method for simultaneous estimation of TLM and 
HCTZ in marketed pharmaceutical formulations, the 
method was first tried for estimation of drugs in 
standard laboratory mixture. Accurately weighed 
TLM (40 mg) and  HCTZ (12.5 mg) were taken in 
100 mL volumetric flask, dissolved in methanol (60 
mL) with the help of ultrasonication for about 10 min 
and the volume was made up to mark  using the same. 
Appropriate aliquot portion (1 mL) was transferred to 
10 mL volumetric flask and further diluted using 50% 
v/v methanol to get TLM (40 g/ mL) and HCTZ 
(12.5 g/ mL). The absorbance was recorded at 296.8 
nm and 271.2 nm against solvent as blank. 
Amount of each drug was estimated using following 
equations, 
 
                    A2 × ay1 - A1 × ay2 
         Cx   =    
                                 ax2 ay1 – ax1 ay2 
 
                                  A1 × ax2- A2× ax1 
        Cy   =      
                                  ax2 ay1 – ax1 ay2 
Where; 
A1 and A2 are the absorbance of diluted mixture at λ1 
and λ2 
Cx and Cy are the concentration of X and Y 
respectively 
ax1 and ax2 are absorptivities of X at λ1 and λ2 
respectively 
ay1 and ay2 are absorptivities of Y at λ1 and λ2 
respectively 
The results are reported in (Table 5). 
Table5: Results of Estimation of Telmisartan and Hydrochlorothiazide Standard Laboratory Mixture 
Sr. 
No. 
Absorbance 
of Mixture 
at 296.8nm 
Absorbance 
of Mixture 
at 271.2 nm 
Amount of 
TLM 
Taken 
(mg) 
Amount of 
TLM 
Estimated  
(mg) 
% TLM 
Estimated 
Amount 
of HCTZ 
Taken 
(mg) 
Amount 
of HCTZ 
Estimate
d (mg) 
% HCTZ 
Estimated 
1. 2.078 2.215 40.05 39.81 99.41 12.58 12.58 100.05 
2. 2.077 2.215 40.10 39.86 99.42 12.51 12.51 100.06 
3. 2.076 2.213 39.95 39.69 99.37 12.55 12.53 99.87 
4. 2.078 2.216 40.13 39.89 99.41 12.55 12.61 100.5 
5. 2.079 2.214 40.15 39.96 99.53 12.57 12.52 99.62 
 Mean 99.42  100.02 
SD 0.0601  0.3222 
% RSD 0.0604  0.3222 
2.8 Application of the Proposed Method for 
Estimation of Drugs in Tablets: Twenty ‘Telista-H’ 
Tablets containing TLM (40 mg) and HCTZ (12.5 
mg) were weighed and ground to fine powder. A 
quantity of sample equivalent to TLM (40 mg) and 
HCTZ (12.5 mg) was transferred into 100 mL 
volumetric flask containing methanol (60 mL), 
sonicated for 15 min and the volume was made up to 
the mark and filtered through Whatman filter paper 
(No. 45). This solution was (1 mL) transferred to 10 
mL volumetric flaks, dissolved and volume was 
adjusted to the mark. The absorbance of the solutions 
were measured at 296.8 nm and 271.2 nm against 
blank. The concentrations of two drugs in sample 
were determined by using simultaneous equations.  
The results are reported in the (Table 6).  
Table6: Results of Estimation of Telmisartan and Hydrochlorothiazide in Tablets. 
2.9 Validation of Proposed Method: 
         The Proposed method was validated as per the 
ICH guidelines. 
1] Accuracy [Recovery Study]:  
Accuracy of proposed method was ascertained on the 
basis of recovery study performed by standard 
addition method. A known amount of standard drug 
solutions were added to the tablet powder to make 
final concentrations in the range of 80%, 100% and 
120% and re-analyzed it by the proposed method.  
The absorbance were recorded and the % recoveries 
were calculated using formula. 
% Recovery = [A - B/ C] X 100 
Where,    
         A = Total amount of drug estimated  
         B = Amount of drug found on preanalysed basis 
         C = Amount of Pure drug added 
Tablet- Telista-H                                                                                                          Average Weight of Tablet- 348.85 mg. 
Sr. 
No. 
Quantity 
Tablet 
Powder 
Taken (mg) 
Absorbance of 
Mixture at 
296.8nm 
Absorbance of 
Mixture at 
271.2 nm 
Amount of Drug 
Estimated (mg) 
% of Drug Estimated. 
 
TLM HCTZ TLM HCTZ 
1. 348.90 2.081 2.212 39.86 12.40 99.65 99.25 
2. 348.82 2.08 2.214 39.83 12.45 99.58 99.62 
3. 348.88 2.078 2.213 39.79 12.46 99.48 99.68 
4. 348.91 2.085 2.211 39.95 12.34 99.88 98.72 
5. 348.87 2.087 2.207 40.02 12.21 100.07 97.72 
 Mean 99.73 98.99 
SD 0.2395 0.8102 
% RSD 0.2401 0.8184 
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The results are reported in (Table 7). 
Table 7: Recovery Study 
Tablet- Telista-H                                                                                           Average Weight of Tablet = 348.85 mg. 
Sr. 
No. 
Quantity 
Tablet 
Powder 
Taken (mg) 
Percentage 
% 
Amount of Pure 
Drug 
Added (mg) 
Total Amount of Drug Recovered 
(mg) 
± S.D. (n = 3) 
% of Drug 
Recovered 
(n = 3) 
TLM HCTZ TLM HCTZ TLM HCTZ 
1. 348.80 80 24.03 7.54 63.22 ±0.017 19.92 ±0.043 98.97 99.11 
2. 348.86 100 40.08 12.52 79.68 ±0.069 24.93 ±0.033 99.62 99.78 
3. 348.82 120 55.85 17.55 95.24 ±0.025 29.62 ±0.056 99.25 98.93 
 
Mean 99.28 99.26 
SD 0.326 0.447 
% RSD 0.328 0.451 
2] Precision: 
Precision was determined as intra-day and inter-day 
variations. Intra-day precision was determined by 
analyzing TLM (19.2, 25.6, and 32 µg/mL) and 
HCTZ (6, 8, and 10 µg/mL) for three times on the 
same day. Inter-day precision was determined by 
analyzing the same concentration of solutions for 
three different days over a period of week. The results 
are reported in (Table 8). 
Table 8: Precision Study 
 
Drug 
 
Conc. 
[µg/mL] 
Intra-day 
Amount Found 
Inter-day 
Amount Found 
Mean 
[N=3] 
% 
R.S.D. 
Mean  [S.D.  
[n = 3] 
% 
 R.S.D. 
TLM 19.2 19.3  
0.01527 
0.0791 19.26  0.0230 0.1198 
25.6 25.7  
0.01520 
0.0591 25.71  0.0231 0.0898 
32 32.18  
0.08082 
0.2511 32.16  0.0577 0.1795 
HCTZ 
 
6 5.91  
0.02 
0.0849 5.89  0.02 0.3395 
8 7.69  
0.02516 
0.3271 7.88  0.0264 0.3356 
10 9.97  
0.04725 
0.04739 9.97  0.0707 0.7091 
3] Ruggedness: Ruggedness of the proposed method 
was determined by analysis of aliquots from 
homogenous slot by two different analyst using same 
operational and environmental conditions. The results 
are reported in (Table 9). 
Table 9: Ruggedness Study 
 TLM  40  µg/mL HCTZ 12.5 µg/mL   
Amount 
Found in  
µg/mL 
Mean  
S.D. (n = 3) 
% 
RSD 
Amount 
Found in  
µg/mL  
Mean  S.D 
(n = 3) 
% 
RSD 
Analyst I 40.17  
0.075498 
0.187
9 
12.41  
0.02645 
0.210
4 
Analyst II 39.98   
0.1892 
0.473
2 
12.57  
0.06658 
0.529
6 
Day-I 39.91  
0.03294 
0.082
4 
12.52   
0.1953 
1.559 
Day-II 39.96  
0.09470 
0.236
9 
12.48  
0.08911 
0.714
0 
4] LOD: Limit of detection of Telmisartan and 
Hydrochlorothiazide were found to be 0.123 μg and 
0.208 μg respectively. 
5] LOQ: Limit of Quantitation of Telmisartan and 
Hydrochlorothiazide were found to be 0.375 μg and 
0.632 μg respectively.   
3. Result and Discussion  
The values of standard deviation are satisfactorily 
low and recovery was close to 100% (99.28 % ) for 
Telmisartan and  (99.26%)  for Hydrochlorothiazide  
indicating reproducibility and accuracy of this 
method. Recovery studies were satisfactory which 
shows that there is no interference of excipients. 
3.1 Method Validation 
Linearity- Linearity of Telmisartan and  
Hydrochlorothiazide  was observed in the range of 5-
30 µg/ml and 2-12µg/ml at all wavelengths 296.8 nm 
and 271.2 nm for one method. The calibration curve 
yielded coefficient of correlation (r) near to 0.9999. 
Assay results-   A tablet dosage form of Telmisartan 
and Hydrochlorothiazide was analyzed by 
Simultaneous equation, the percentage in dosage form 
were determined and presented, 99.73 %& 98.99 
%.Assay results obtained are within limit. 
Accuracy and precision –The low values of % RSD 
interval indicate that method is precise. % recovery 
by using simultaneous equation method was found to 
be within limit indicate the non interference from the 
formulation excipients and confirm the accuracy and 
precision of the method. 
 
4. Conclusion 
   All above results indicate that, the 
Simultaneous equation method employed here are 
very simple, accurate, economical, and rapid for 
routine analyses of drug, Telmisartan and 
Hydrochlorothiazide. The recovery was 99.28 % and 
99.26% for simultaneous equation method, which is 
close to 100% indicating reproducibility & accuracy 
of method.  
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